Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 17 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 17 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS
06 - May - 2025 12:00 | 26 days ago
J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,77,208 equity shares of Re. 1 each to 15,57,42,894 equity shares of Re. 1 each.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 17 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS
06 - May - 2025 12:00 | 26 days ago
J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,77,208 equity shares of Re. 1 each to 15,57,42,894 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 17 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 17 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS
06 - May - 2025 12:00 | 26 days ago
J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,77,208 equity shares of Re. 1 each to 15,57,42,894 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 17 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 17 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS
06 - May - 2025 12:00 | 26 days ago
J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,77,208 equity shares of Re. 1 each to 15,57,42,894 equity shares of Re. 1 each.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 17 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS
06 - May - 2025 12:00 | 26 days ago
J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,77,208 equity shares of Re. 1 each to 15,57,42,894 equity shares of Re. 1 each.
